Tarsus Pharmaceuticals, Inc. Common Stock (TARS) is a publicly traded Healthcare sector company. As of October 28, 2026, TARS trades at $71.43 with a market cap of $3.28B and a P/E ratio of -67.48. TARS moved +0.45% today. Year to date, TARS is -12.39%; over the trailing twelve months it is +3.81%. Its 52-week range spans $38.51 to $91.53. Analyst consensus is strong buy with an average price target of $100.88. Rallies surfaces TARS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks hedge fund and 13F ownership for TARS, including fund holders, share counts, and position changes when data is available.
| Metric | Value |
|---|---|
| Price | $71.43 |
| Market Cap | $3.28B |
| P/E Ratio | -67.48 |
| EPS | $-1.08 |
| Dividend Yield | 0.00% |
| 52-Week High | $91.53 |
| 52-Week Low | $38.51 |
| Volume | 60.65K |
| Avg Volume | 0 |
| Revenue (TTM) | $606.33M |
| Net Income | $-46.48M |
| Gross Margin | 0.00% |
9 analysts cover TARS: 0 strong buy, 9 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $100.88.